Hyundai Bioscience (048410.KQ) Earnings Analysis

Hyundai Bioscience (048410.KQ) has no confirmed upcoming earnings date. Trailing P/E -28.97.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 048410.KQ next report earnings?

No confirmed upcoming earnings date is currently scheduled for 048410.KQ. This page updates as the calendar is published.

048410.KQ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-16-49.35 KRWn/an/an/a
2025-11-12-73 KRWn/an/an/a
2025-08-18-48.41835 KRWn/an/an/a
2025-05-15-69.88418 KRWn/an/an/a
2025-03-10-114.91639 KRWn/an/an/a
2024-11-14-121.42249 KRWn/an/an/a
2024-08-1457.94 KRWn/an/an/a

048410.KQ valuation and analyst view

Trailing P/E-28.97
Trailing EPS-221.57322 KRW
Price / book5.63
Dividend yield0.00%
Market cap576.12B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Hyundai Bioscience (048410.KQ)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 048410.KQ. This page updates as the calendar is published.

Did 048410.KQ beat earnings last quarter?

Consensus estimate data was not available for 048410.KQ's 2026-03-16 report.

What is 048410.KQ's current P/E ratio and EPS?

048410.KQ trades at a trailing P/E of -28.97 on trailing EPS of -221.57322031045533 KRW.

What do analysts rate 048410.KQ?

048410.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.